Last reviewed · How we verify

NCT05269043

Advanced Telemonitoring of Patients With COPD in Home Environment

Completed Last updated 29 January 2024
What this trial tests

trial testing Medimonitor in COPD in 25 participants. Completed in 1 February 2023.

Timeline
14 October 2022
Primary endpoint
1 February 2023
1 February 2023

Quick facts

Lead sponsorUniversity Hospital Olomouc
StatusCompleted
Study typeOBSERVATIONAL
Enrollment25
Start date14 October 2022
Primary completion1 February 2023
Estimated completion1 February 2023
Sites1 location across Czechia

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital Olomouc

Who can join

60 and older, any sex, with COPD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Chronic obstructive pulmonary disease (COPD) is one of the leading and rising causes of morbidity and mortality worldwide. The most important etiopathogenetic agent is smoking. However, air-pollution probably also plays a crucial role in the disease development, progression and exacerbations. The multimodal-telemedicine approach may provide a useful tool in the patient follow-up with the aim to reduce disease exacerbation rate and improve the health-related quality of life. The study aims to investigate the effects and utility of advanced telemonitoring in elderly COPD patients. All data will be integrated in a single web-based platform in order to analyse the mutual effects of different conditions and variables.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Machine learning approach to flare-up detection and clustering in chronic obstructive pulmonary disease (COPD) patients.
    Rueda R, Fabello E, Silva T, Genzor S, et al · · 2024 · cited 1× · PMID 39464698 · DOI 10.1007/s13755-024-00308-4

Verify or expand the search:

Other trials of Medimonitor

Trials testing the same drug.

Other recruiting trials for COPD

Currently open trials in the same condition.

Other University Hospital Olomouc trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05269043.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing